This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paccani, S. R.
Right arrow Articles by Baldari, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paccani, S. R.
Right arrow Articles by Baldari, C. T.

 Previous Article  |  Next Article 

Infection and Immunity, July 2008, p. 2822-2832, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00200-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Suppression of T-Lymphocyte Activation and Chemotaxis by the Adenylate Cyclase Toxin of Bordetella pertussis{triangledown}

Silvia Rossi Paccani,1 Federica Dal Molin,2 Marisa Benagiano,3 Daniel Ladant,4 Mario M. D'Elios,3 Cesare Montecucco,2 and Cosima T. Baldari1*

Department of Evolutionary Biology, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy,1 Department of Biomedical Sciences, University of Padua, Via Trieste 75, 35121 Padua, Italy,2 Department of Internal Medicine and Immunoallergology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy,3 CNRS URA 2185, Department of Structural Biology and Chemistry, Institut Pasteur, 75724 Paris Cedex 15, France4

Received 13 February 2008/ Returned for modification 17 March 2008/ Accepted 7 April 2008

The adenylate cyclase toxin (CyaA) released by Bordetella pertussis is an essential virulence factor for colonization of the host. This toxin inhibits migration and activation of phagocytes, thereby preventing bacterial killing. In addition, CyaA interferes with the initiation of adaptive immunity by misdirecting dendritic cell differentiation to a suppressive rather than stimulatory phenotype. Here we show that CyaA directly affects adaptive responses by catalyzing cyclic AMP (cAMP) production in peripheral blood lymphocytes. Treatment with CyaA resulted in profound impairment of T-lymphocyte activation and chemotaxis. These effects resulted from inhibition of T-cell antigen receptor and chemokine receptor signaling via a cAMP/protein kinase A (PKA)-dependent pathway. A comparison of the activities of CyaA on T-cell and macrophage activation and migration revealed that the biological effects of the toxin were paralleled by inhibition of the activation of mitogen-activated protein (MAP) kinases, highlighting the conclusion that the ubiquitous and evolutionarily conserved MAP kinase modules are common targets of the PKA-mediated immunosuppressant activities of CyaA and underlining the potential of cAMP-elevating toxins as a means of evasion of immunity by bacterial pathogens.


* Corresponding author. Mailing address: Department of Evolutionary Biology, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. Phone: 39-0577-234400. Fax: 39-0577-234476. E-mail: baldari{at}unisi.it

{triangledown} Published ahead of print on 21 April 2008.

Editor: S. R. Blanke


Infection and Immunity, July 2008, p. 2822-2832, Vol. 76, No. 7
0019-9567/08/$08.00+0     doi:10.1128/IAI.00200-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schneider, O. D., Weiss, A. A., Miller, W. E. (2009). Pertussis Toxin Signals through the TCR to Initiate Cross-Desensitization of the Chemokine Receptor CXCR4. J. Immunol. 182: 5730-5739 [Abstract] [Full Text]  
  • Wang, X., Barnes, P. F., Dobos-Elder, K. M., Townsend, J. C., Chung, Y.-t., Shams, H., Weis, S. E., Samten, B. (2009). ESAT-6 Inhibits Production of IFN-{gamma} by Mycobacterium tuberculosis-Responsive Human T Cells. J. Immunol. 182: 3668-3677 [Abstract] [Full Text]